M
Maria Buti
Researcher at Carlos III Health Institute
Publications - 604
Citations - 32028
Maria Buti is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Hepatitis B virus & Hepatitis B. The author has an hindex of 71, co-authored 493 publications receiving 26596 citations. Previous affiliations of Maria Buti include University of Kiel & Hebron University.
Papers
More filters
Journal ArticleDOI
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
Pietro Lampertico,Kosh Agarwal,Thomas Berg,Maria Buti,Harry L.A. Janssen,George V. Papatheodoridis,Fabien Zoulim,Frank Tacke +7 more
TL;DR: This Clinical Practice Guideline presents updated recommendations for the optimal management of HBV infection, and future treatment strategies to achieve 'cure' of disease and new biomarkers are discussed.
Journal ArticleDOI
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam H. Afdhal,Stefan Zeuzem,Paul Y. Kwo,Mario Chojkier,Norman Gitlin,Massimo Puoti,Manuel Romero-Gómez,Jean-Pierre Zarski,Kosh Agarwal,Peter Buggisch,Graham R. Foster,Norbert Bräu,Maria Buti,Ira M. Jacobson,G. Mani Subramanian,Xiao Ding,Hongmei Mo,Jenny C. Yang,Phillip S. Pang,William T. Symonds,John G. McHutchison,Andrew J. Muir,Alessandra Mangia,Patrick Marcellin +23 more
TL;DR: Once-daily ledipasvir-sofosbuvir with or without ribavirin for 12 or 24 weeks was highly effective in previously untreated patients with HCV genotype 1 infection.
Journal ArticleDOI
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
David Ellinghaus,Frauke Degenhardt,Luis Bujanda,Maria Buti,Agustín Albillos,Pietro Invernizzi,J. Fernández,Daniele Prati,Guido Baselli,Rosanna Asselta,Marit Mæhle Grimsrud,Chiara Milani,Fatima Aziz,Jan Christian Kässens,Sandra May,Mareike Wendorff,Lars Wienbrandt,Florian Uellendahl-Werth,Tenghao Zheng,Xiaoli Yi,Raúl de Pablo,Adolfo Garrido Chercoles,Adriana Palom,Alba Estela Garcia-Fernandez,Francisco Rodriguez-Frias,Alberto Zanella,Alessandra Bandera,Alessandro Protti,Alessio Aghemo,Ana Lleo,Andrea Biondi,Andrea Caballero-Garralda,Andrea Gori,Anja Tanck,Anna Carreras Nolla,Anna Latiano,Anna Ludovica Fracanzani,Anna Peschuck,Antonio Julià,Antonio Pesenti,Antonio Voza,David Jiménez,Beatriz Mateos,Beatriz Nafria Jimenez,Carmen Quereda,Cinzia Paccapelo,Christoph Gassner,Claudio Angelini,Cristina Cea,Aurora Solier,David Pestana,Eduardo Muñiz-Diaz,Elena Sandoval,Elvezia Maria Paraboschi,Enrique Navas,Félix García Sánchez,Ferruccio Ceriotti,F. Martinelli-Boneschi,Flora Peyvandi,Francesco Blasi,Luis Téllez,Albert Blanco-Grau,Georg Hemmrich-Stanisak,Giacomo Grasselli,Giorgio Costantino,Giulia Cardamone,Giuseppe Foti,Serena Aneli,Hayato Kurihara,Hesham ElAbd,Ilaria My,Iván Galván-Femenía,Javier Martin,Jeanette Erdmann,José Ferrusquía-Acosta,Koldo Garcia-Etxebarria,Laura Izquierdo-Sanchez,Laura Rachele Bettini,Lauro Sumoy,Leonardo Terranova,Leticia Moreira,Luigi Santoro,Luigia Scudeller,Francisco Mesonero,Luisa Roade,Malte C. Rühlemann,Marco Schaefer,Maria Carrabba,Mar Riveiro-Barciela,Maria Eloina Figuera Basso,Maria Grazia Valsecchi,María Hernández-Tejero,Marialbert Acosta-Herrera,Mariella D'Angiò,Marina Baldini,Marina Cazzaniga,Martin Schulzky,Maurizio Cecconi,Michael Wittig,Michele Ciccarelli,Miguel Rodríguez-Gandía,Monica Bocciolone,Monica Miozzo,Nicola Montano,Nicole Braun,Nicoletta Sacchi,Nilda Martinez,Onur Özer,Orazio Palmieri,Paola Faverio,Paoletta Preatoni,Paolo Bonfanti,Paolo Omodei,Paolo Tentorio,Pedro Castro,Pedro M. Rodrigues,Aaron Blandino Ortiz,Rafael de Cid,Ricard Ferrer,Roberta Gualtierotti,Rosa Nieto,Siegfried Goerg,Salvatore Badalamenti,Sara Marsal,Giuseppe Matullo,Serena Pelusi,Simonas Juzenas,Stefano Aliberti,Valter Monzani,Victor Moreno,Tanja Wesse,Tobias L. Lenz,Tomás Pumarola,Valeria Rimoldi,Silvano Bosari,Wolfgang Albrecht,Wolfgang Peter,Manuel Romero-Gómez,Mauro D'Amato,Stefano Duga,Jesus M. Banales,Johannes R. Hov,Trine Folseraas,Luca Valenti,Andre Franke,Tom H. Karlsen +145 more
TL;DR: A 3p21.31 gene cluster is identified as a genetic susceptibility locus in patients with Covid-19 with respiratory failure and a potential involvement of the ABO blood-group system is confirmed.
Journal ArticleDOI
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin,Edward Gane,Maria Buti,Nezam H. Afdhal,William Sievert,Ira M. Jacobson,Mary Kay Washington,George Germanidis,John F. Flaherty,Raul Aguilar Schall,Jeffrey D. Bornstein,Kathryn M. Kitrinos,G. Mani Subramanian,John G. McHutchison,E. Jenny Heathcote +14 more
TL;DR: In patients with chronic HBV infection, up to 5 years of treatment with tenofovir DF was safe and effective, and long-term suppression of HBV can lead to regression of fibrosis and cirrhosis.
Journal ArticleDOI
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
Devin Razavi-Shearer,Ivane Gamkrelidze,Mindie H. Nguyen,Ding-Shinn Chen,Pierre Van Damme,Zaigham Abbas,Maheeba Abdulla,Antoine Abou Rached,Danjuma Adda,Inka Aho,Ulus Salih Akarca,Fuad Hasan,Faryal Al Lawati,Khalid Al Naamani,Hamad I. Al-Ashgar,Seyed M Alavian,Sameer Alawadhi,Agustín Albillos,Said A. Al-Busafi,Soo Aleman,Faleh Z. Al-Faleh,Abdulrahman Aljumah,Anil C. Anand,Nguyen Thu Anh,Joop E. Arends,Perttu Arkkila,Kostas Athanasakis,Abate Bane,Ziv Ben-Ari,Thomas Berg,Abdul Rahman Bizri,Sarah Blach,Carlos E Brandão Mello,Samantha M Brandon,Bisi Bright,Philip Bruggmann,Maurizia Rossana Brunetto,Maria Buti,Henry Lik-Yuen Chan,Asad Chaudhry,Rong-Nan Chien,Moon Seok Choi,Peer Brehm Christensen,Wan-Long Chuang,Vladimir Chulanov,Mette Rye Clausen,Massimo Colombo,Markus Cornberg,Benjamin C Cowie,Antonio Craxì,E. A. Croes,Diego Alberto Cuellar,Chris Cunningham,Hailemichael Desalegn,Sylvia Drazilova,Ann-Sofi Duberg,Steve S Egeonu,Manal H El-Sayed,Chris Estes,Karolin Falconer,Maria Lucia Gomes Ferraz,Paulo R. Ferreira,Robert Flisiak,Sona Frankova,Giovanni Battista Gaeta,Javier García-Samaniego,Jordan Genov,Jan Gerstoft,Adrian Goldis,Ilias Gountas,Richard Gray,Mario G. Pessoa,Behzad Hajarizadeh,Angelos Hatzakis,Christophe Hézode,Sayed Himatt,Andy I. M. Hoepelman,Irena Hrstić,Yee Tak Hui,Petr Husa,Rohani Jahis,Naveed Z. Janjua,Peter Jarcuska,Jerzy Jaroszewicz,Sabahattin Kaymakoglu,David Kershenobich,Loreta A. Kondili,Aliya Konysbekova,Mel Krajden,Pavol Kristian,Wim Laleman,Wai-cheung C Lao,Jen Layden,Jeffrey V. Lazarus,Mei Hsuan Lee,Valentina Liakina,Young-Suk Lim,Ching-kong K Loo,Boris Lukšić,Reza Malekzadeh,Abraham O. Malu,Adkhamjon Mamatkulov,Michael Manns,Rui Tato Marinho,Mojca Matičič,Stefan Mauss,Muhammad S. Memon,Maria C Mendes Correa,Nahum Méndez-Sánchez,Shahin Merat,Ammal M. Metwally,Rosmawati Mohamed,Jacques E Mokhbat,Christophe Moreno,Joël Mossong,Fadi H. Mourad,Beat Müllhaupt,Kimberly Murphy,Erkin Musabaev,Arif Nawaz,Helen Nde,Francesco Negro,Alexander Nersesov,Van Thi Thuy Nguyen,Richard Njouom,Renovat Ntagirabiri,Zuridin Nurmatov,Solomon Obekpa,Ponsiano Ocama,Stephen Oguche,Ogu Omede,CE Omuemu,Ohene Opare-Sem,Christopher K Opio,Necati Örmeci,George V. Papatheodoridis,Ken Pasini,N. N. Pimenov,Hossein Poustchi,Trân D Quang,Huma Qureshi,Alnoor Ramji,Kathryn Razavi-Shearer,Berhane Redae,Henk W. Reesink,Cielo Yaneth Rios,Gabriela Rjaskova,Sarah Robbins,Lewis R. Roberts,Stuart K. Roberts,Stephen D. Ryder,Rifaat Safadi,Olga Sagalova,Riina Salupere,Faisal M. Sanai,Juan Francisco Sánchez-Ávila,Vivek A. Saraswat,Christoph Sarrazin,Jonathan Schmelzer,Ivan Schréter,Julia A. Scott,Carole Seguin-Devaux,Samir Shah,Ala I. Sharara,Manik Sharma,Gamal Shiha,Tesia Shin,William Sievert,Jan Sperl,Peter Stärkel,Catherine A.M. Stedman,Vana Sypsa,Frank Tacke,Soek Siam Tan,Junko Tanaka,Krzysztof Tomasiewicz,Petr Urbánek,Adriaan J. van der Meer,Hans Van Vlierberghe,Stefano Vella,Adriana Vince,Yasir Waheed,Imam Waked,Nick Walsh,Nina Weis,Vincent Wai-Sun Wong,Joseph Woodring,Cesar Yaghi,Hwai I. Yang,Chung-Lin Yang,Kakharman Yesmembetov,Ayman Yosry,Man-Fung Yuen,Muhammed Aasim M Yusuf,Stefan Zeuzem,Homie Razavi +195 more
TL;DR: The estimate of HBV prevalence in 2016 differs from previous studies, potentially because it took into account the effect of infant prophylaxis and early childhood vaccination, as well as changing prevalence over time.